Superior Biologics is a leading home infusion and specialty pharmacy provider offering services to pediatric & adult populations suffering.
Superior Biologics has raised $135.6M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2022.
Superior Biologics's investors include Oxford Finance LLC, CIT Healthcare Finance.
Superior Biologics is headquartered in Hawthorne, United States.
Superior Biologics is a leading home infusion and specialty pharmacy provider offering services to pediatric & adult populations suffering.
Superior Biologics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Superior Biologics — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/superior-biologics. Accessed August 16, 2026.
VCBacked. (2022). Superior Biologics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/superior-biologics
{{cite web |title=Superior Biologics — Funding & Investors |url=https://www.vcbacked.co/company/superior-biologics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated